Jakarta, July 14 -- Japanese biopharmaceutical firm Takeda will invest up to $30 million (approximately Rp539 billion) to develop a plasma-derived medicinal product network in Indonesia, the Ministry of Investment and Downstreaming announced on Tuesday.

The capital injection marks the first phase of a two-year plan aimed at establishing a national plasma bank network to build domestic capacity for the industry.

"This strategic investment goes beyond providing capital by creating opportunities for technology transfer, workforce development, and high-skilled employment," Investment and Downstreaming Minister Rosan Roeslani said in a statement.

Roeslani stated the partnership aligns with government efforts to advance downstreaming policie...